CD14 and TNFα single nucleotide polymorphisms are candidates for genetic biomarkers of peri-implantitis

Clinical Oral Investigations

Volumn 19, Issue 4, 2015, Pages 791-801

  Rakic, Mia ^a   Petkovic Curcin, Aleksandra ^b   Struillou, Xavier ^c   Matic, Smiljana ^b   Stamatovic, Novak ^b   Vojvodic, Danilo ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

Biomarker; CD14; Peri implantitis; Polymorphism; RANKL; TNF

Indexed keywords

CD14 ANTIGEN; GENETIC MARKER; TUMOR NECROSIS FACTOR;

ADULT; AGED; FEMALE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; PERIIMPLANTITIS; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; AGED; ANTIGENS, CD14; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PERI-IMPLANTITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84928242354     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-014-1313-3     Document Type: Article

References (54)

1. Hämmerle CH, Glauser R (2004) Clinical evaluation of dental implant treatment. Periodontol 2000 34:230–239
2. Watts N (1999) Clinical utility of biochemical markers of bone remodeling. Clin Chem 45:1359–1368
3. Heitz-Mayfield LJ (2008) Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol 35:292–304
4. Wilson C, Schulz S, Waldman SA (2007) Biomarker development, commercialization, and regulation: individualization of medicine lost in translation. Clin Pharmacol Ther 81:153–155
5. Isidor F (1996) Loss of osseointegration caused by, occlusal load of oral implants. A clinical and radiographic study in monkeys. Clin Oral Implants Res 7:143–152
6. Esposito M, Hirsch JM, Lekholm U, Thomsen P (1998) Biological factors contributing to failures of osseointegrated oral implants. (ii). Etiopathogenesis. Eur J Oral Sci 106:721–764
7. Lang NP, Berglundh T (2011) Periimplant diseases: where are we now?—Consensus of the Seventh European Workshop On Periodontology. J Clin Periodontol 38(Suppl 11):178–181
8. Isidor F (1997) Histological evaluation of peri-implant bone at implants subjected to occlusal overload or plaque accumulation. Clin Oral Implants Res 8:1–9
9. Heitz-Mayfield LJ, Lang NP (2010) Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis. Periodontol 2000 53, 167–81.
10. Yoshinaga Y, Ukai T, Abe Y, Hara Y (2007) Expression of receptor activator of nuclear factor kappa B ligand relates to inflammatory bone resorption, with or without occlusal trauma, in rats. J Periodontal Res 42:402–409
11. Laine ML, Morré SA, Murillo LS, van Winkelhoff AJ, Peña AS (2005) CD14 and TLR4 gene polymorphisms in adult periodontitis. J Dent Res 84:1042–1046
12. Amano S, Kawakami K, Iwahashi H, Kitano S, Hanazawa S (1997) Functional role of endogenous CD14 in lipopolysaccharide-stimulated bone resorption. J Cell Physiol 173:301–309
13. Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, Nishijima M et al (2000) Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. Biochem Biophys Res Commun 268:172–177
14. Boyce BF, Li P, Yao Z, Zhang Q, Badell IR, Schwarz EM, O’Keefe RJ, Xing L (2005) TNF-alpha and pathologic bone resorption. Keio J Med 54:127–131
15. Duarte PM, de Mendonca AC, Maximo MBB, Santos VR, Bastos MF, Nociti Junior FH (2009) Differential cytokine expressions affect severity of peri-implant disease. Clin Oral Implants Res 20:514–520
16. Offenbacher S, Heasman PA, Collins JG (1993) Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 64:432–444
17. Offenbacher S (1996) Periodontal diseases: pathogenesis. Ann Periodontol 21:206–209
18. Yoshie H, Kobayashi T, Tai H, Galicia JC (2000) The role of genetic polymorphisms in periodontitis. Periodontol 43:102–132
19. Fransson C, Lekholm U, Jemt T, Berglundh T (2005) Prevalence of subjects with progressive bone loss at implants. Clin Oral Implants Res 16:440–446
20. Roos-Jansaker AM, Lindahl C, Renvert H, Renvert S (2006) Nine- to fourteen-year follow-up of implant treatment. Part I: implant loss and associations to various factors. J Clin Periodontol 33:283–289
21. Roos-Jansaker AM, Lindahl C, Renvert H, Renvert S (2006) Nine- to fourteen-year follow-up of implant treatment. Part II: presence of periimplant lesions. J Clin Periodontol 33:290–295
22. Roos-Jansaker AM, Renvert H, Lindahl C, Renvert S (2006) Nine- to fourteen-year follow-up of implant treatment. Part III: factors associated with peri-implant lesions. J Clin Periodontol 33:296–301
23. Fransson C, Tomasi C, Pikner SS, Grondahl K, Wennstrom JL, Leyland AH et al (2010) Severity and pattern of peri-implantitis-associated bone loss. J Clin Periodontol 37:442–448
24. Vaz P, Gallas MM, Braga AC, Sampaio-Fernandes JC, Felino A, Tavares P (2012) IL1 gene polymorphisms and unsuccessful dental implants. Clin Oral Implants Res 23:1404–1413
25. Kinane DF, Shiba H, Hart TC (2005) The genetic basis of periodontitis. Periodontol 2000 39:91–117
26. Kroeger KM, Steer JH, Joyce DA, Abraham LJ (2000) Effects of stimulus and cell type on the expression of the 308 tumor necrosis factor promoter polymorphism. Cytokine 12:110–119
27. Holla LI, Buckova D, Fassmann A, Halabala T, Vasku A, Vacha J (2002) Promoter polymorphisms in the CD14 receptor gene and their potential association with the severity of chronic periodontitis. J Med Genet 39:844–848
28. Van Aken J (1969) Optimum conditions for intraoral roentgenograms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 27:475–491
29. Petković AB, Matić SM, Stamatović NV, Vojvodić DV, Todorović TM, Lazić ZR, Kozomara RJ (2010) Proinflammatory cytokines (IL-1b and TNF-a) and chemokines (IL-8 and MIP-1a) as markers of peri-implant tissue condition. Int J Oral Maxillofac Implants 39:478–485
30. Pjetursson BE, Helbling C, Weber H-P, Matuliene G, Salvi GE, Bragger U, Schmidlin K, Zwahlen M, Lang NP (2012) Periimplantitis susceptibility as it relates to periodontal therapy and supportive care. Clin Oral Impl Res 23:888–894
31. Roccuzzo M, Bonino F, Aglietta M, Dalmasso P (2012) Ten-year results of a three arms prospective cohort study on implants in periodontally compromised patients. Part 2: clinical results. Clin Oral Impl Res 23:389–395
32. Campos MI, dos Santos MC, Trevilatto PC, Scarel-Caminaga RM, Bezerra FJ, Line SR (2004) Early failure of dental implants and TNF -alpha (g-308a) gene polymorphism. Implant Dent 13:95–101
33. Cury PR, Joly JC, Freitas N, Sendyk WR, Nunes FD, de Araújo NS (2007) Effect of tumor necrosis factor-alpha gene polymorphism on peri-implant bone loss following prosthetic reconstruction. Implant Dent 16:80–88
34. Cury PR, Horewicz VV, Ferrari DS, Brito R Jr, Sendyk WR, Duarte PM, Shibli JA (2009) Evaluation of the effect of tumor necrosis factor-alpha gene polymorphism on the risk of peri implantitis: a case–control study. Int J Oral Maxillofac Implants 24:1101–1105
35. Zhang J, Sun X, Xiao L, Xie C, Xuan D, Luo G (2011) Gene polymorphisms and periodontitis. Periodontol 2000(56):102–124
36. Graves DT, Jiang Y, Genco C (2000) Periodontal disease: bacterial virulence factors, host response and impact on systemic health. Curr Opinions Infect Dis 13:227–232
37. Leonhardt A, Grondahl K, Bergstrom C, Lekholm U (2002) Long-term follow-up of osseointegrated titanium implants using clinical, radiographic and microbiological parameters. Clin Oral Implants Res 13:127–132
38. Löe H, Anerud A, Boysen H, Morrison E (1986) Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol 13:431–445
39. Folwaczny M, Glas J, Torok HP, Mende M, Folwaczny C (2004) Lack of association between the TNFa G 308 A promoter polymorphism and periodontal disease. J Clin Periodontol 31:449–453
40. Smith AJ, Humphries SE (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 20:43–59
41. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS (1997) Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontology 2000 14:216–248
42. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ (2001) Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. J Biol Chem 276:21129–21135
43. Means TK, Golenbock DT, Fenton MJ (2000) The biology of Toll-like receptors. Cytokine Growth Factor Rev 11:219–232
44. Cochran D (2008) Inflammation and bone loss in periodontal disease. J Periodontol 79(Suppl 8):1569–1576
45. Donati M, Berglundh T, Hytönen AM, Hahn-Zoric M, Hanson LA, Padyukov (2005) Association of the −159 CD14 gene polymorphism and lack of association of the −308 TNFA and Q551R IL-4RA polymorphisms with severe chronic periodontitis in Swedish Caucasians. J Clin Periodontol 32:474–479
46. Rakic M, Lekovic V, Nikolic-Jakoba N, Vojvodic D, Petkovic-Curcin A, Sanz M (2013) Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. Clin Oral Implants Res 24:1110–1116
47. Rakić M, Nikolić-Jakoba N, Struillout X, Petković-Curcin A, Stamatović N, Matić S, Janković S, Aleksić Z, Vasilić D, Leković V, Vojvodić D (2013) Receptor activator of nuclear factor kappa B (RANK) as a determinant of peri-implantitis. Vojnosanit Pregl 70:346–351
48. Arikan F, Buduneli N, Kütükçüler N (2008) Osteoprotegerin levels in peri-implant crevicular fluid. Clin Oral Implants Res 19:283–288
49. Arikan F, Buduneli N, Lappin DF (2011) C-telopeptide pyridinoline crosslinks of type i collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with periimplantitis: a case–control study. Int J Oral Maxillofac Implants 26:282–289
50. Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, Atilla G, Hughes FJ, Belibasakis GN (2007) Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 34:370–376
51. Buduneli N, Kinane DF (2011) Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol 38 (Suppl) 11:85–105.
52. Dereka X, Mardas N, Chin S, Petrie A, Donos N (2012) A systematic review on the association between genetic predisposition and dental implant biological complications. Clin Oral Implants Res 23:775–788
53. Albouy JP, Abrahamsson I, Berglundh T (2012) Spontaneous progression of experimental peri-implantitis at implants with different surface characteristics. An experimental study in dogs. J Clin Periodontol 39:182–187
54. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S (1999) Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25:255–259